Myocardial hypertrophy and hyperplasia. A narrative of past, present and future.

The heart of man is noble, but then 'noblesse oblige'. Obligated to what? Obviously, the heart — a muscular pump driven by electricity — is obliged to maintain the driving force of circulation. Once circumstances change, necessitating the heart to increase work, its response will be to adapt. In adults, cardiac adaptation is achieved by hypertrophy, defined as an increase in volume of myocytes, mainly because the cells synthesize additional contractile proteins. The intracellular remodelling depends on the type of load.' Where there is an increase in pressure load the number of sarcomeres increase in a parallel fashion, thus creating a distinct increase in the cross-sectional diameter of the myocytes. In volume load hypertrophy, on the other hand, the increase in the number of sarcomeres is mainly longitudinal, thus causing the cells to elongate rather than to exhibit an increase in diameter. The heart is thus equipped to cope with an increase in demand, albeit under pathological conditions at the expense of an imbalance between energy consumption and production — a negative effect, which in part relates to a decrease in coronary vasodilator reserve'"'.

[1]  G. Gibbons,et al.  Molecular Mechanisms of Vascular Renin‐Angiotensin System in Myointimal Hyperplasia , 1991, Hypertension.

[2]  S. Grajek Hypertrophy or hyperplasia in cardiac muscle? postmortem human morphometric study , 1991 .

[3]  A. Katz,et al.  Angiotensin II: hemodynamic regulator or growth factor? , 1990, Journal of molecular and cellular cardiology.

[4]  E. Marbán,et al.  Cell calcium, oncogenes, and hypertrophy. , 1990, Hypertension.

[5]  B. Healy,et al.  Coronary reserve is depressed in postmyocardial infarction reactive cardiac hypertrophy. , 1990, Circulation.

[6]  G. Cooper,et al.  Load Responsiveness of Protein Synthesis in Adult Mammalian Myocardium: Role of Cardiac Deformation Linked to Sodium Influx , 1989, Circulation research.

[7]  P. Simpson Role of proto-oncogenes in myocardial hypertrophy. , 1988, The American journal of cardiology.

[8]  Y. Yazaki,et al.  Expression of Cellular Oncogenes in the Myocardium During the Developmental Stage and Pressure‐Overloaded Hypertrophy of the Rat Heart , 1988, Circulation research.

[9]  P. Ganz,et al.  Angiotensin II Stimulation of Vascular Smooth Muscle Phosphoinositide Metabolism State of the Art Lecture , 1987, Hypertension.

[10]  G Olivetti,et al.  Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review. , 1986, Journal of the American College of Cardiology.

[11]  K. Kaibuchi,et al.  Possible involvement of protein kinase C and calcium ion in growth factor-induced expression of c-myc oncogene in Swiss 3T3 fibroblasts. , 1986, The Journal of biological chemistry.

[12]  Karol Sikora,et al.  ONCOGENES , 1983, The Lancet.

[13]  M. Marcus,et al.  Effects of Duration and Severity of Arterial Hypertension and Cardiac Hypertrophy on Coronary Vasodilator Reserve , 1982, Circulation research.

[14]  D. Allen,et al.  The effects of muscle length on intracellular calcium transients in mammalian cardiac muscle. , 1982, The Journal of physiology.

[15]  W Grossman,et al.  Cardiac hypertrophy: useful adaptation or pathologic process? , 1980, The American journal of medicine.

[16]  F. Manasek,et al.  MITOSIS IN DEVELOPING CARDIAC MUSCLE , 1968, The Journal of cell biology.

[17]  L. Reiner,et al.  The weight of the human heart. II. Hypertensive cases. , 1961, Archives of pathology.

[18]  A J LINZBACH,et al.  Heart failure from the point of view of quantitative anatomy. , 1960, The American journal of cardiology.

[19]  L REINER,et al.  The weight of the human heart. I. Normal cases. , 1959, A.M.A. archives of pathology.